Turn this role into an interview — a resume and cover letter built around what this employer wants.
PharmaEssentia USA is seeking an experienced Hematology Business Manager to lead sales for BESREMi® across an assigned region. You will educate hematology/oncology professionals and drive adoption through strategic territory plans and cross-functional collaboration.
The role emphasizes patient focus, data-driven execution, and a startup mindset to navigate access challenges and optimize market opportunities in a dynamic, growth-focused biopharma environment.
About PharmaEssentia: It’s not often you get the chance to make a real impact on the lives of others, while expanding your own possibilities. You’ll find that rare opportunity at PharmaEssentia. Join us, and let’s transform lives, together. PharmaEssentia Corporation is a rapidly growing biopharmaceutical innovator. We are leveraging deep expertise and proven scientific principles to deliver effective new biologics for challenging diseases in the areas of hematology and oncology, with one product approved and a diversifying pipeline. We believe in the potential to improve both health and quality of life for patients with limited options today through the combination of rigorous research and innovative thinking. Founded in 2003 by a team of Taiwanese-American executives and renowned scientists from U.S. biotechnology and pharmaceutical companies, today we are listed on the Taiwan Stock Exchange (TWSE: 6446) and are expanding our global presence with operations in the U.S., Japan, Singapore, South Korea, and China, along with a world-class biologics production facility in Taichung.
PharmaEssentia is seeking an experienced Hematology Business Manager with a strong patient focus and a passion for driving results for its commercial product, BESREMi®. This position is responsible for all sales activities in an assigned geographical area and will be expected to maximize sales achievement through promotion of PharmaEssentia products to approved, targeted customers and distribution channels. You will build and execute strategic territory plans across stakeholders involved in patient care in order to educate customers about BESREMi® and address the various needs along the treatment adoption process. Customers include hematologists/oncologists, nurses, pharmacists, pharmacy and therapeutics groups, teaching institutions, hospitals and formulary committees.
The expected base salary range for this position is $180,000 to $200,000. Salary offers are based on a wide range of factors including relevant skills, training, experience, education and geographical location. Market and organizational factors are also considered. In addition to base salary and a competitive benefits package, successful candidates are eligible for short-term and long-term incentives.
At PharmaEssentia USA, we are committed to providing an environment of mutual respect where equal employment opportunities are available to all applicants without regard to race, color, religion, sex, pregnancy (including childbirth and related medical conditions), national origin, age, physical and mental disability, marital status, sexual orientation, gender identity, gender expression, genetic information (including characteristics and testing), military and veteran status, and any other characteristic protected by applicable law. PharmaEssentia USA believes that diversity and inclusion among our team are critical to our success as a global company, and we seek to recruit, develop and retain the most talented people from a diverse candidate pool.
PharmaEssentia does not accept unsolicited agency resumes. Staffing agencies should not send resumes to our HR team or to any PharmaEssentia employees. PharmaEssentia is not responsible for any fees related to unsolicited resumes from staffing agencies.
At PharmaEssentia, our goal is to treat as many people with cancer as possible. That means challenging the status quo with better science that leads to better lives. By joining our team, you will not only expand your own possibilities, but you will contribute to expanding options for people with cancer.